subscribe
 

New 2-3 day patient-applied product for sun-damaged skin that can lead to skin cancer

A new treatment for sun-damaged skin that can lead to skin cancer is launched by LEO Pharma

Curie-Cancer and Biolog-id sign partnership agreement

Within the partnership, Curie-Cancer and Biolog-id will develop a pilot system of RFID tags suitable for use in tracking cancer chemotherapy preparations

Sub-Visible Particles: impact on therapeutic proteins

SP Scientific has announced a new LyoLearn webinar, due to run on 27th June 2013, entitled 'Sub-visible Particles: Impacts on Aggregation...

£250k prize offered to encourage human toxicology breakthrough

A £250k prize is being offered to encourage researchers to deliver a breakthrough in toxicology research that could ultimately lead to the...

Roche presents new, fully automated lab solution at Europe’s largest diagnostics conference

System improves efficiency and speed of blood sample testing in medical labs

Auxogyn selected to present at European BioEquity Conference in Stockholm

BioEquity is the top European event for life science investors showcasing companies on the forefront of innovation.

Queen’s scientists develop ‘magic bullet’ nanomedicine for Acute Lung Injury

Researchers at Queen’s University Belfast have devised a ‘magic bullet’ nanomedicine which could become the first effective treatment for Acute Lung Injury or ALI, a condition affecting 20 per cent of all patients in intensive care.

Novartis drug Ilaris® approved by FDA

Novartis announced that the US Food and Drug Administration (FDA) has approved Ilaris® (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients aged 2 years and older.

New nanoparticles research

A Wayne State University researcher has successfully tested a technique that can lead to more effective use of nanoparticles as a drug delivery system.

Study finds nearly 5 million asthmatics worldwide could benefit from antifungal therapy

An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from the University of Toronto and Manchester University.

GlaxoSmithKline announces start of phase III study of Benlysta®

GlaxoSmithKline plc (GSK) has announced the start of a Phase III study to evaluate Benlysta® (belimumab) in patients with ANCA (Anti-neutrophil Cytoplasmic Antibodies) positive vasculitis

Roche launches new test for diagnosis and monitoring of thyroid cancer

Roche has announced the launch of Elecsys Calcitonin, a new laboratory test for the diagnosis and lifelong monitoring of medullary thyroid cancer patients after thyroid surgery.

Can eradicating a common stomach bug make taking aspirin safer?

Researchers have launched a major clinical trial to investigate whether eliminating a common stomach bug could help to make taking aspirin safer in some patients.

Researchers solve puzzle of proteins linked to heart failure

Sudden cardiac death is a risk for patients with heart failure because the calcium inside their heart cells is not properly controlled and this can lead to an irregular heartbeat. New findings reveal mechanisms that underlie this...

Why the brain is more reluctant to function as we age

New findings, led by neuroscientists at the University of Bristol and published this week in the journal Neurobiology of Aging, reveal a novel mechanism through which the brain may become more reluctant to function as we grow older.

Half of care home patients suffer drug errors

Errors in administration of medication are a serious problem in long-term residential care. A new electronic medication management system...

Direct extraction/analysis of dried blood spots

A fully automated system has been developed for the extraction of DBS cards that can be coupled directly to the MS or LC-MS system

Flow methodology for highly reproducible bromination reactions

Uniqsis has announced an application note that describes a continuous flow methodology for electrophilic bromination that offers excellent...

Cortisone can increase risk of acute pancreatitis

A new study from Karolinska Institutet in Sweden shows that cortisone - a hormone used in certain medicines - increases the risk of acute pancreatitis.

Roche launches new process for accessing clinical trial data

Roche has announced that it is expanding access to its clinical trial data for third party researchers.

Pages

Newsbrief

Twitter Icon © Setform Limited
subscribe